Medin induces pro‐inflammatory activation of human brain vascular smooth muscle cells
Physiological Reports · 2025-06 · 13 (11)
DOI: 10.14814/phy2.70418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 11.06.2025. Verfasst von Nina Karamanova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Phoenix Veterans Affairs Health Care System, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | National Institutes of Health (NIH), NIA NIH HHS, U.S. Department of Veterans Affairs (VA).
Abstract (Originalsprache)
Medin, a common amyloidogenic protein, accumulates in the vasculature with aging. We evaluated the effects of medin on human brain vascular smooth muscle cell (VSMC) activation. VSMCs were exposed to medin (0.5, 1, and 5 μM) without or with the small molecule nuclear factor‐κB (NFκB) inhibitor RO106‐9920 (10 μM). Polymerase chain reaction, Western blot/enzyme‐linked immunosorbent assays were used to quantify gene and protein expressions/secretions, respectively, of pro‐inflammatory factors (interleukin (IL)‐6, IL‐8, and monocyte chemoattractant protein (MCP)‐1) and structural and enzyme proteins associated with VSMC phenotypic transformation (smooth muscle actin alpha 2 (ACTA2), myosin heavy chain 11 (MYH11) and NADPH oxidase 4 (NOX4)). Medin increased VSMC gene expression and protein secretion of IL‐6, IL‐8, and MCP‐1 (protein secretion 46.0 ± 12.8x, 20.2 ± 4.1x, and 8.7 ± 3.1x, respectively, medin 5 μM versus vehicle, p < 0.05). There was no change in gene/protein expressions of ACTA2, MYH11, and NOX4. Co‐treatment with RO106‐9920 reduced medin‐induced increases in IL‐6 and IL‐8 with a trend towards reduced MCP‐1 secretion. Medin induced pro‐inflammatory activation of human brain VSMCs that is mediated in part by NFκB. Acute medin treatment did not alter structural proteins involved in VSMC phenotypic transformation. The findings support medin as a potential novel mediator of and therapeutic target for vascular aging pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Phoenix Veterans Affairs Health Care System, Phoenix, Arizona, USA.
- University of Liverpool, Liverpool, UK.
- University of Arizona, College of Medicine, Phoenix, Arizona, USA.
ORCID-Profile: Raymond Q Migrino
Förderung
- HHS | National Institutes of Health (NIH)
- NIA NIH HHS
- U.S. Department of Veterans Affairs (VA)
- BLRD VA
- RRD VA
- National Institutes of Health
Zitieren
APA
Karamanova, N., Morrow, K. T., Maerivoet, A., Madine, J., Li, M., & Migrino, R. Q. (2025). Medin induces pro‐inflammatory activation of human brain vascular smooth muscle cells. Physiological Reports, 13(11). https://doi.org/10.14814/phy2.70418
Vancouver
Karamanova N, Morrow KT, Maerivoet A, Madine J, Li M, Migrino RQ. Medin induces pro‐inflammatory activation of human brain vascular smooth muscle cells. Physiological Reports. 2025;13(11). doi:10.14814/phy2.70418
BibTeX
@article{Karamanova2025,
author = {Karamanova, Nina and Morrow, Kaleb T and Maerivoet, Alana and Madine, Jillian and Li, Ming and Migrino, Raymond Q},
title = {Medin induces pro‐inflammatory activation of human brain vascular smooth muscle cells},
journal = {Physiological Reports},
year = {2025},
volume = {13},
number = {11},
doi = {10.14814/phy2.70418}
}
EUVIMED